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Abstract: The cornrnentaries on our target article have raised important issues about central neuroplasticity and its role in persistent pain
states. Sorne suggest that central neuroplasticity plays nothing rnore than a minor role in persistent pain, while others argue that persistent
pain depends critically on peripheral inputs for its rnaintenance. Sorne stress that persistent pain relies to a large extent on changes in the
brain and on centrifugal inputs frorn brain to spinal cord, whereas others argue that it depends on alterations in inhibitory as well as
excitatory systerns. We attempt to address each of the cornrnentators' points, while defending our position that central neuroplasticity is
critical to pathological persistent pain states.
Whether one calls it central hyperexcitability, sensitization,
or neuroplasticity, the critical role of changes in central
nervous system (CNS) function in persistent pain have
been stressed both in our own target article and in the
others in this issue of BBS. It is clear from the commen-
taries that the concept of noxious stimulus- or injury-
induced central changes has captured the attention ofpain
researchers world-wide. What is also clear is that there are
many ideas and opinions about the nature of these changes
and the extent to which they contribute to the pathophysiol-
ogy of persistent pain. In an effort to integrate the large
amount of material provided in the many insightful com-
mentaries, we would like to draw the reader's attention to
speciffc themes that have arisen, as well as to outline our
own view on them. Despite the disparate views, we believe
the commentaries have one thing in common. They all ask:
What is the principal role of central neuroplasticity in
persistent pain? Most agree that central changes play a role
in pain processing, but some argue that peripheral pathol-
ogy is central to its expression, and thus to persistent pain.
Others argue that although central changes are key players
in pathological pain, a greater emphasis should be placed
on changes in the brain and the influence of the brain on
spinal cord. Finally, still others point out, as we have, that
central changes are important, but that the importance of
changes in inhibitory rather than excitatory mechanisms
must be stressed.
Determining the relative contribution of central changes
and peripheral"inputs is critical to answering the questioiof
whether central neuroplasticity contributes to persistent
pain. The issues raised in the commentaries can be con-
densed into four key questions. (1) Does central neuro-
plasticity exist? (2) If it exists, what role does it play in
persistent pain in animal models or human clinical pain? (3)
Are peripheral inputs more important than central changes
for the expression of persistent pain? (4) Can neuro-
plasticity exist in the absence of continued or ongoing
peripheral inputs? Most of the commentators seem to
accept that central neuroplasticity exists. It would be dif{i-
cult to ignore the growing body of experimental evidence
demonstrating several forms of central neuroplasticity in-
cluding wind-up, dorsal horn neuronal sensitization, and
receptive {ield expansions, as well as hyperexcitable flexion
reflexes and nerve injury-induced sprouting and the pro-
duction of dark neurons in dorsal horn. However. it is
possible to argue, as do Cleland & Gebhart, that central
neuroplasticity plays only an insignificant role in animal and
human experimental hyperalgesia models. Marchettini et
al. add that what occurs in animal experimental models may
have little to do with what happens in human cases of
chronic clinical pain. Furthermore, it is also possible to
argue, as do both Devor and Gracely, that although
central plasticity exists, from a treatment perspective it may
be more appropriate to target the peripheral pathology that
maintains it rather than the central site where it occurs. On
the other hand, there is support from Jancs6 et al. and
from Willis to suggest that central sensitization can be
maintained in the absence of continued sensory input. Hu
& Sessle go on to suggest that central sensitization in
trigeminal nociceptive pathways may depend on an un-
masking or strengthening of convergent inputs.
Cleland & Gebharthave come to a different conclusion
based on additional studies and their appreciation ofcertain
critical technical limitations. However, these additional
studies do not rule out a role for central neuroplasticity in
hyperalgesia. Thus, the studies of Puig and Soikin (1996),
Dubner and Ruda (1992), and Woolf et al. (1992) indicate
that peripheral injuries lead to changes in afferent activity,
neuromediator release, and structural alterations that are
present duringboth the development and the maintenance
of hyperalgesia associated with these injuries. In each of
these cases, however, the hyperalgesia-inducing injury is
also associated wlth prolonged peripheral tissue changes.
Thus, it is not unreasonable to expect central changes to
accompany both phases of the response. It is important to
realize that central neuroplasticity and continued inputs
from the periphery are not mutually exclusive. However,
when ongoing peripheral inputs are present, they obscure
our ability to demonstrate that hyperalgesia is in part due to
central changes. Even rvhen using so-called direct methods
(i.e., preinjury and postinjury block), results can be con-
founded if the injury is intense enough to produce pro-
longed peripheral changes. Thus, if intense peripheral
inputs outlast a preinjury block then the block is unlikely to
produce pre-emptive effects. On the other hand, if an
important consequence of central sensitization is to amplify
peripheral inputs, then eliminating peripheral inputs with a
postinjury block may often eliminate nociceptive responses
and hyperalgesia. These results do not rule out central
neuroplasticity; they only stress that in many instances pain
behaviour requires peripheral input to be fully expressed, a
conclusion that we have espoused in our target article. On
more technical grounds, we find it sulprising that Cleland
& Gebhart accept that effective anesthesia was produced
by 50 pl of lidocaine in the study of Dallel et al. (1995)
whereas they discount the anesthetic effect with a much
larger volume (150 pl) of the longer lasting anesthetic
bupivicaine in the study of Coderre et al. (1990). We were
also somewhat surprised that a 50Vo reduction in with-
drawal latency, signi{icant at a p-value of (0.01, was
deemed only weakly signiftcant in the study of Coderre and
Melzack (i985), while a stated nonsignificant trend in the
study of McCall et al. (1996) was intJrpreted as significant
by Cleland & Gebhart.
Marchettini et al. are more receptive to the concept of
central plasticity, but they remain doubtful that it plays a
role in persistent human pain states. They correctly point
out that there are examples of chronic clinical pain for
which there are no experimental animal models. We agree
that clinical and experimental pain are not identical, but we
maintain that insights into the pathophysiologr of clinical
pain can be derived from experimental models. Even ani-
mal models as simple as the mouse tail-flick test have
provided considerable information about the analgesic effi-
cacy of various pharmaceutical compounds. It is true,
however, that we are in need of additional animal models of
chronic pain with demonstrated validity for human pain
conditions. It should be noted that in human experimental
trials, phenomena such as wind-up (Price et al. lg94) and
hyperexcitability offlexion reflexes (Dahl et al. 1992) have
been demonstrated and probably play a role in clinical pain.
The fact that many human conditions 
- 
e.g., arthritis, soft
tissue injury and procedures such as nerve biopsies 
- 
do
not lead to chronic pain in the absence ofpersistent injury is
not proof that central plasticity does not exist, but only
reinforces the point that there are fortunately other physi-
ological mechanisms at work that undermine its expression
and long-term survival. Unfortunately, there are probably
other cases where these protective mechanisms are unable
to overcome the negative consequences ofcentral neuro-
plasticity or peripheral sources of pathology.
Marchettini et al. may be right that genetic differences
may play a key role in determining who is at risk for
developing chronic pain, as has been well articulated by
Devor and Raber (1990), and that human coqnition can
lead to suppression or augmentation of pain perception and
can produce variability in human pain behaviour that is less
likely or dramatic in animal models. We agree with Back-
onja, who argues that neuropathic pain is an intricate
condition that cannot be explained by neuroplasticity alone.
A complex interaction between peripheral pathology, CNS
changes, and reactive emotive processing must be taken
into account.
Both Devor and Gracely make the point that central
neuroplasticity is selective and not striking in intensity and
hence that targeting the peripheral pathologr would be a
more effective treatment. We agree that there has recently
been an overemphasis on central mechanisms in the expla-
nation of persistent pain states, Howeveq until recent years
there was barely a recognition that central plasticity played
any role at all in persistent pain. Over the last several years
there has been a growing recognition that central plasticity
exists and plays a role in persistent pain. In the introduction
ofany new idea, there is a tendency to overstate its signifi-
cance. Throughout the target article we made an effort, as
did Gracely et al. (1992), to bring peripheral mechanisms
back into the picture and to focus on the interaction
between peripheral and central mechanisms of persistent
pain- We stress that in some clinical pain states peripheral
mechanisms may dominate, whereas central mechanisms
may be more important in others. It is true that there has
been an explosion in the literature on novel centrally acting
agents, such as N-methyl-D-aspartate (NMDA) antagonists
for the treatment of persistent pain. Perhaps for"many
patients such a treatment is neither appropriate nor effec-
tive. However, there may also be a group of patients who do
not respond when peripheral pathologies are targeted but
are responsive to such a central treatment (Backonja et al.
1994; Eide et al. 1994; Kristensen et al. 1992; Nikolajsen et
al. 1996). Rather than seeing central treatments as taigeting
an all-inclusive, ffnal common pathway, it may be more
instructive to think of them as alternatives. to be used when
agents targeting the peripheral pathologlz are ineffective. It
is for this reason that we must not be too quick to dismiss
new treatment possibilities.
Generally, we agree with Devor and Gracely that in
many instances central sensitization is probably not so
much pathologlz as a natural response of the CNS to
peripheral pathologr. It is clear, however, that CNS neurons
are capable, in some instances, ofdeveloping pathological
characteristics (i.e., epileptic foci). Because neurons in-
volved in pain transmission share neurochemical sim-
ilarities with those involved in epilepsy, including glutamate
activity at NMDA receptors, it is not inconceivable that, as
suggested in the commentary by Backonja, such central
pathologies may contribute to some persistent pain states.
Furthermore, as discussed by jancs6 et al., peripheral
nerve injuries result in progressive structural changes in
pain transmission pathways, including transganglionic de-
generation of C-fiber primary afferents, sprouting of large
fibers into substantia gelatinosa, and a ieorganLation "of
spinal dorsal horn neuronal connections, all central changes
which could contribute signiftcantly to the developmeniof
persistent pain after nerve injury. Also, as described by Hu
& Sessle, central sensitization that is evident in trigeminal
nociceptive patlrways may depend on an unmaiking ot
strengthening of convergent inputs. Since neuroplasticity is
more effectively induced by noxious deep inputs, Hu &
Sessle also suggest this may explain why greater sensory
disturbances occur after injury to deep tissues than after
iniurv to cutaneous tissues.
-The 
question remains as to whether central sensitization
can be sustained in the absence of continued inputs from
the periphery. Gracely has given evidence of persistent
clinical pain states where inputs from the periphery are
necessary and in our target article we have given clinical
examples in which it is possible that inputs from the
penpbery q9 no! necessary to sustain central h;,perex-
citability. Although Gracely does not rule out the possi-
bility, Cleland & Gebhart and Devor are more skeptical,
and Ursin, in contrast, supports even the concept oT self-
sustainin_g positive feedback loops. Jancs6 et al. argue that
sustained central sensitization is possible, becauie after
intracisternal injection of capsaicin a mechanical hyper-
algesia developsin the skin aiea that becomes compieiely
insensitive to further noxious chemical stimulation. Fur-
thermore, both jancs6 et al. and Willis point out that
capsaicin injection tothe skin produces a signiftcant hyper-
algesia that is dependent on central sensitization. Hole et
al. and Birbaumer & Flor further support this concept
and argue that sustained central sensitization could be
explained by mechanisms similar to those involved in learn-
ing and memory processes.
Hole et aI. review the data from their own as well as four
independent studies that suggest that phenomena such as
long-term potentiation may exist in spinal cord dorsal horn.
In relation to the mechanisms triggering sensitization,
Willis describes how the sensitization of spinothalamic
tract neurons induced by intradermal capsaicin is mimicked
by excitatory mediators such as glutamate and substance P
and blockeci byboth NMDA and\Kl receptor antagonists,
as well as inhibitors ofvarious protein kinases. jancs6 et al.
also refer to evidence that perineural treatment with cap-
saicin produces transganglionic degeneration of C-ffber
primary afferents and extensive sprouting of large fibers
within the substantia gelatinosa, resulting in alterations in
connectivity similar to"those produced by'peripheral nerve
sections. This evidence is all quite significant, since, as we
point out in our target article, the hyperalgesia produced by
capsaicin typically long outlives the duration of its initial
afferent barrage.
Devor raises an important question: What is there about
the theory of central sensitization that wo uId predtct stantp -
i.ng i,n of an ingrown toenail, but not an episiotomy scar?
Our model proposes that reactivation of a somatosensory
pain memory requires a drive and that this drive may
originate in the periphery DRG, spinal cord, or brain. In
the case of amputation, we need to consider whether the
loss of normal sensory nerve impulses (deafferentation)
that follows amputation in some way plays a role in either
the stamping in process, the re-activation stage, or both. We
have previously argued that the interruption of afferent
input associated with amputation or deafferentation may
facilitate the central neural changes that contribute to the
formation of pain memories by reinoving normal inhibitory
control mechanisms (Coderre et al. 1993). There are,
however, examples of pain memories recurring in the
absence ofobvious deafferentation, although it is true that
the example of postepisiotomy pain raised 6y Devor is not
among them. Thus, cardiac pain had been referred to the
site of a compression fracture in the upper back (Henry &
Montuschi 1978) and pain in response to stimulation of the
nasal mucosa may be referred to teeth that had recently
been fflled (Hutchins & Relnolds 1947; Reynolds &
Hutchins 1948). It appears then that deafferentation may
not necessarily play a role in the stamping in of a pain.
What abouithle iole of deafferentation in'the reactivation
of an established pain trace? The most important difference
between a phantom ingrown toenail and an episiotomy scar
is that the fonner has no peripheral referent, since the body
part has been surgically removed. We need to consider
some of the less obvious implications of this fact for the re-
activation of a pain trace aiter amputation. In addition to
the loss of afferent input that results fiom amputation of a
body part, there is also a loss of visual, tactile, and pro-
prioceptive information related to the limb; it can no longer
be seen. touched. or felt. What is the effect of this loss of
information on the perception of a phantom? We would
argue that the cortical and subcortical influences that
normally inhibit established pain traces may be further
reduced by the absence of information from sense modal-
ities that might otherwise confirrn or disconfirm the per-
cept (e.g., of a painful ingrown toenail) arising from the
periphery. Following amputation, the likelihood of re-
activating a pain memory that had a visual component (e.g.,
ingrown toenail) is increased because the potential inhiE-
tory effect ofvision has also been removed. In general, as
the number of modalities involved in the pre-ainputation
pain experience increases (and thus the more soirrces of
potential feedback are removed), so does the probabllity of
re-activating a past pain once the limb has been removed.
This could occurbecause there are fewer senses available to
prgvrde a reality-based check (i.e., exert an inhibitory
influence) on the perceptual processes generating the
phantom (Katz 1993).
- 
Implicit in any discussion of memory is the assumption
that the CNS has been changed as a function of prior
experience. Although we did not explicitly re{er tolearning
in our target article, we agree with Hole et al., Birbaumei
& Flor, and Watkins & Maier that learning processes
must underlie expressions of new behaviour. Peihaps the
most fascinating example of this in the phantom limb pain
Iiterature is leirned paralysis (Ramaciandran 19g4i in
which the brain has leamed that an immobile phantom
hand cannot be moved. An extremely creative solution is to
use mirrors to trick the brain into thinking that the phantom
is moving by having the amputee look intd a mirrorihile his
contralateral intact hand is positioned to coincide spatially
with the felt position of the phantom hand. When the
amputee attempts to carry out the same movement with
both hands while loohng at the phantom (1.e., reflection of
the intact hand), the sight of the hand moving determines
the ultimate perception, and the amputee feels as if the
gnge p?ralyled hand is now moving freely. This experiment
highlights the dominant role of vision over othei sensory
modalities in circumstances involvinq exteroceptive sensi-
bility. There are other examples of thYs intermoiul it t"gru-
tion and perceptual dominace of vision (Katz 1993). Pa-
tients undergoing brachial plexus or spinal local
anaesthestic b-locki and patienti with complete brachial
plexus avulsiols or spinal-cord transections all report vivid
phantom limbs that are felt to be coincident -with the
postion of the real limb as determined by sight. However,
when a patient's deafferented limb is moved from one
position to another with eyes closed. the felt position of the
phantom corresponds to the last seen position of the real
limb. When patients open their eyes, the phantom is
reported to fuse with the new position of the ieal limb as
perceived by sight. These examples demonstrate that we
are dealing with a perception system that is even more
complex than the traditional supraspinal pain signalling
system envisioned by Hardcastle in her commentary.
There is no doubt, as Benedetti argues, that psychologi-
cal factors play a role in the perceptioriof pain afie.."rg""ry
It is for this reason that we routinely administer the multi-
dimensional McGill Pain Questionnaire in our studies of
pre-emptive analgesia (Katz et al. 1994; Katz et al. 1996a;
Katz et al, 1992). We have also administered other mea-
sures of psychological and emotional functioning, including
anxiety and depression (Kavanagh et al. 1994). Although we
and others have found that pre-operative administration of
analgesics or local anesthetic agents can pre-empt post-
operative pain, we have yet to find any differential effects of
these psychological factors on analgesic requirements after
sr1ggry. A recent prospective follow-up study of patients
who had undergone lateral thoracotomy showed tilatS2Vo
of patients repirted daily or weekly"pain of moderate
intensity approximately 1.5 years after surgery (Katz et al.
1996b). The interesting ffnding was that postoperative pain
within 6 hours of surgery was the only signiftcant predictor
of long-term pain. In contrast, pre- and postoperative
measures of anxietyand depressive symptomologywere not
predictive, suggesting that these psychological factors did
not differentially influence the experience or reporting of
pain. While psychological factors are important, too much
emphasis on them may bhnd clinicians and researchers to
other potentially significant predictors of longterm pain 
-
in this case, intense postoperative pain.
As noted above, the model we developed in the target
article allows for the maintaining drive to originate from
brain regions either directly or indirectly involved in the
processing of nociceptive information. As we did not em-
phasize this possibility in the target article, we welcome the
commentary by Watkins & Maier who brine into focus a
novel line ,if fui" research involving brain-t6-spinal cord
circuitry. Whereas it is well established that noxious periph-
eral stimulation leads to a sensitization of spinal cord
neurons, Watkins & Maier introduce the novel concept
that centrifugal brain to spinal cord pathways allow de-
scending inputs from brain centers such as the nucleus
raphe magnus to facilitate nociceptive processing in spinal
cord as well.
Along similar lines, Benedetti discusses the role of
nociceptive emotional integration in the limbic system and
its relation to pathological pain; and Ursin raises the
possibility of the brain generating and maintaining sensiti-
zation in the absence of peripheral input. Elsewhere, we
have outlined a mechanism through which cognitive and
affective processes associated with higher cortical and lim-
bic centers may alter phantom limb sensations via either
brain-to-brain or brain-to-spinal cord circuitry (Katz 1996).
As an example of the latter, phantom limb pain intensity
may be modulated bv higher brain centers involved in
cognitive and affective pr6""sr"r via a multis;maptic net-
work of descending inputs that impinges on preganglionic
s;..rnpathetic neurons in the lateral horn of the spinal cord.
These descending inputs would subsequently produce dif-
fuse peripheral autonomic discharge and activation of pri-
mary afferent {ibers located in stump neuromas. This
activity would, in turn, project to spinal cord dorsal horn
neurons subserving the amputated limb and to rostral brain
structures where the impulses contribute to the perception
of pain. Consistent with the learning model outlined by
Birbaumer & Flor in their commentary. we have oro-
posed (Katz 1993) that through repeated activation, neural
circuitry is strengthened among brain regions subserving
cognitive, affective, and sensory processes. Hence phantom
limb sensations and pain may be triggered by thoughts and
feelings in the abseice of piimary ifferent ieedba"ck from
peripheral structures.
Clarke is right in pointing out that our target article
concentrated heavily on excitatory mechanisms rather than
inhibitory mechanisms. It is quite true that failure of
inhibitory mechanisms could underlie some forms of
pathological pain. Indeed, this possibility is discussed in
greater detail in the accompanying target articles of Drcx-
ENsoN and WInsrNFEL-HALLTN ET AL. Furthermore,
many of the most effective treatments that clinicians use
today (opiates, cr2-adrenergic agonist and tricyclic anti-
depressants) are based on the enhancement of inhibitory
systems rather than suppression of exictatory systems.
These treatments are available today because of the re-
search efforts into inhibitory systems (endogenous opioids,
descending control circuits, etc.) in the 1970s and early
1980s, This is precisely why it is necessary to develop a
better understanding of the excitatory mechanisms that
play a role in persistent pain. The accelerated pace of
research into excitatory mechanisms (neuropeptides, excit-
atory amino acids) in the late 1980s and 1990s promises to
deliver novel clinical treatments that will give us additional
options to alleviate persistent pain.
To respond to a specific comment from Clarke about
referred pain: we did not mean to suggest that referred pain
relies on tonic inputs from the area of referral but rather
that referred pain is influenced by additional inputs from
the area ofreferral. Unless one proposes an axon-ieflexlike
peripheral response in the referred area, this conclusion is
necessary to explain how referred pain sensations can be
reduced by local anesthesia of the referred area. In re-
sponse to Marchettini et al., we wish to point out that we
did not intend to equate phantom limb pain with referred
pain and that in the final analysis we described phantom
limb pain as pain that is projected (not referred) to the
amputated legion. Last, in response to Devort stated
paradox about AB-fiber input producing both increased
inputs and counterstimulation-induced decreased inputs:
(1) There is no requirement that central sensitization relia-
bly render AB-fiber input painful, and (2) counterstimula-
tion is most often produced by heterosegmental sensory
input.
No brain, no pain
Zsuzsanna Wiesenfeld-Hallin
Karolinska Institute, Department of Medical Laboratory Sciences and
Technology, Section of Clinical Neurophysiology, 3-141 86 Huddinge,
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Abstrach The theme of rny target article was dysfunction of inhibition in the spinal cord as an irnportant factor in the developrrent of
chronic pain states. Some commentaries focused on the role of rnore central mechanisrns and the limited usefulness of anirnal rnodels for
understanding mechanistns of human pain. More specific cornments concerned the roles of GABA and cholecystokinin in pain control.
The commentaries can divided into broad categories deal- learrring (Birbaumer & Flor, Hole et al., Watkins &
ing with the following issues: Maier)] central effects of infection/inflammation (Wat-
1, Spinal mechanisms are inadequate to describe the kins&Maier),corticalfunctions,andemotions(Hardcas-
pathophysiologr underlying chronic pain because not tle). Pain facilitating circuits descending from the brain to
enough attention has been focused on conditioning and the spinal cord may have a key role in fhe organization of
response to pain. Furthermore, it is unquestionable that
mechanisms rostral to the spinal cord are of great impor-
tance in pain perception and suffering. However, the em-
phasis of this review was on spinal mechanisms because a
better understanding of these should offer great hope for
therapies, with minimal side effects. Of course, pains that
involve structures central to the spinal cord, such as
thalamic or idiopathic pains, cannot be treated in the same
way as pains arising from peripheral or spinal pathol-
ogy.
2. Animal studies are of limited use in understanding
clinical human conditions (Marchettini et al.). It is un-
doubtedly true that human pain and suffering reported
verbally cannot be duplicated, for obvious reasons, in ani-
mals. However, after careful analysis of animal behavior one
can certainly detect abnormalities that might be relevant to
the human experience. More speciffcally, abnormal pain-
like behaviors that can be alleviated by drugs (Wiesenfeld-
Hallin et al. 1997) and other therapies, such as spinal cord
stimulation (Stiller et al. 1996), that are useful in humans
for pain relief should be considered as evidence for the
relevance of the animal model. In discussing the reduced
analgesic effect of opiates reported by some clinicians, but
not others, Marchettini et al. write that mahng "compre-
hensive hypotheses on neuropathic pain without consider-
ing divergent reports seems simplistic." However, such
reports are considered under section 4.L (para,2) in the
target article, and even in our own animal studies we have
found reduced potency of intrathecal morphine following
axotomy, ratherthan atotal lackof effect (Xu &Wiesenfeld-
Hallin 1991). If the potency of opiates is indeed reduced in
neuropathic pain, physicians need to consider carefully
whether "analgesia" after large doses has a large sedative
component. The sedative effect of systemic morphine in
experimental pain states can be analyzed with careful
behavioral techniques (Xu et al. 1992). Furthermore, com-
prehensive hlpothesis about neuropathic pain is proposed,
but there is a suggestion that there may be some common
mechanisms. As pointed out by Siddall, different models of
neuropathy ( axotomy vs. partial nerve inj ury) may h av e v ery
different mechanisms. If has recently 6een demonstratel
that there are considerable differences among various
models of partial nerve injury (Kim et al. f997)-
3. A number of neurotransmitter systems are involved in
the mediation of chronic pain. The iarget article concen-
trates on two systems: 1-amino butyric acid (GABA) and
cholecystokinin (CCK). The role of GABA in the mediatins
of chronic pain states may involve both the GABA-A ani
GABA-B receptor in both spinal and trigeminal pathways(Hu & Sessle). Furthermore. dvsfunction of the CASA-
ergic system me.y differ in pain states with varying etiologies(Omote, Siddall).
CCK's role as an antianalgesic or antiopioid is now widely
accepted, on the basis of pioneering studies from a number
of laboratories (IIan, Noble et al., Watkins & Maier).
Although the functional role for such a mechanism from the
evolutionary point of view may seem counterintuitive(Clarke), there are very interesting hyptheses about a role
for CCK as a negative feedback coritrol for endogenous
opioids (Han). In spite of a great deal of research on the
antiopioid action of CCK, however, the precise mechanism
of action is not well understood. There is general agreement
about an interaction between the CCK ind the riu-opioid
receptor, but there is divergence ofopinion about whether
there is also an important interaction between the rc (Han)
or 6 opioid (Benoliel et al. 199f ) receptors. An important
therapeutical possibility for CCK antagonists wouldalso be
t-o increase the analgesic effect of inhibitors of enkephalin-
degrading enzqes,which increase the potency of endoge-
nous opio-ids (Noble etal.). Like all neuroactive substancies,
CCK has a number of functions in the central and peripheral
nervous systems, including being a potent anxiogenic when
applied exogenously (Benedetti). In fact, highly selective
CCK-B antagonists have been found to have a potent
anxiolytic action in rodents (Hughes et al. lgg0). It is
tempting to suggest that clinically useful CCK antagonists
could have a double beneffcial effect, by reducins the
sensory and affective/anxiogenic aspects o? pain.
R2. Definition
We were aware of recent changes in nomenclature from the
interrrational association for the study ofpain regarding the
"complex regional pain syndrome" (CRPS) (Merskey &
Bogduk 1994). Nevertheless, for one group of patients
we-found it reasonable at this stage of"the discussion to
continue using the term "reflex srrmpathetic dystrophy"
Sympathetic contribution to pain 
- 
need for
clarification
Helmut Blumberg,. Ulrike Hoffman,b Mohsen Mohadjer,.
and Rudolf Scheremet"
aDepaftment of Neurosurgety, University of Freiburg, 79106 Freiburg,
Germany; oDepartment of Anesthesiology, University of Freiburg, 79106
Freiburg, Germany. boeger@nz1 1.ukl.uni-freiburg.de
Abstract-: Certain_patients with a possible contribution of tlie synrpathetic systern to pain may not fit the definition of complex regional
pain sprdrornes (CRPS_), which raises the_ question- of tenninology for thoie patienti. To further clarify the relaUonship tet-eJ.r th"
ipnpath^etic system and pain, apart frorn tli6 need for placebo studies, there rimains an urgent need foi a satisfactory d6{inition of the
critgri-a for.a cornplete sympathetic block. It also remains uncertain whether a change in the discharge pattern of synpathetic fibres
underlies the changes in synpathetic organ function, often found in patients with CRPS.
R1. lntroduction
Our target article received a number of thoughtful and well
structured commentaries. It was not possible, nor was it our
intention, to clarify all aspects of the relationship between
the syrnpathetic system and pain. The commentaries ac-
cordingly show that there is a need to clarify the con-
tribution of the sympathetic system to pain states.
